Nastaran Majdinasab
Overview
Explore the profile of Nastaran Majdinasab including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
455
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rezatofighi A, Soltani M, Latifi S, Majdinasab N, Safari Z, Varmazyar M, et al.
Dysphagia
. 2025 Mar;
PMID: 40038124
Multiple Sclerosis (MS) is a common chronic disease among young adults. It affects various aspects of Quality of Life (QOL). Dysphagia is a problem associated with neurological damage in MS...
2.
Afshari P, Abedi P, Majdinasab N, Tafakh S, Haghighizadeh M
Front Neurol
. 2025 Jan;
15():1514157.
PMID: 39871990
Background: Multiple sclerosis (MS) is a debilitating autoimmune disease that mostly affects women. Objectives: In this study we evaluated the relationship of pelvic muscle strengths with urinary incontinence and quality...
3.
Keramatzadeh S, Hosseini S, Majdinasab N, Cheraghian B, Zilaee M
Nutr Neurosci
. 2024 Nov;
:1-9.
PMID: 39565038
Objectives: Resveratrol, a polyphenol found in grapes, has been studied extensively for its potential benefits on metabolic markers and inflammation. While promising results have been observed in animal studies and...
4.
Sahraian M, Abolfazli R, Shaygannejad V, Ashtari F, Majdinasab N, Navardi S, et al.
Sci Rep
. 2024 Oct;
14(1):24921.
PMID: 39438591
Multiple sclerosis is an inflammatory demyelinating disease and represents a global health concern. Ocrelizumab, a humanized IgG monoclonal antibody, selectively targets CD20 on B cells and CD20-expressing T cells. This...
5.
Ashtari F, Kavosh A, Baghbanian S, Hosseini Nejad Mir N, Hosseini S, Razazian N, et al.
Clin Neurol Neurosurg
. 2024 Mar;
239:108216.
PMID: 38490075
Objective: The relationship between MS and ethnicity has been understudied in the Middle East compared to the United States and Europe. As Iran as the highest prevalence of MS in...
6.
Majdinasab N, Sadrian M, Kashipazha D, Moradi M
Curr J Neurol
. 2023 Nov;
19(3):103-106.
PMID: 38011421
The study aimed to judge the safety and possible side effects of rituximab (RTX) drug in patients with multiple sclerosis (MS). This retrospective observational study was performed on 91 patients...
7.
Khalatbari Mohseni G, Hosseini S, Majdinasab N, Cheraghian B
Neuropsychopharmacol Rep
. 2023 Jun;
43(3):382-390.
PMID: 37386885
Aim: N-acetylcysteine (NAC), a thiol-containing antioxidant and glutathione (GSH) precursor, attenuates oxidative stress, and possibly improves psychiatric disorders. This study aimed to evaluate the effects of oral NAC on oxidative...
8.
Dastoorpoor M, Nabavi S, Majdinasab N, Javid A, Angali K, Seyedtabib M
J Health Popul Nutr
. 2023 Mar;
42(1):22.
PMID: 36959679
Background: There is no study in the world on the relationship between consuming black and green tea as beverages containing polyphenols and the risk of MS. This study aimed to...
9.
Majdinasab N, Orakifar N, Kouti L, Shamsaei G, Seyedtabib M, Jafari M
Front Neurosci
. 2023 Mar;
17:1107886.
PMID: 36895417
Introduction: Overactive bladder (OAB) is one of the most common complications in patients with multiple sclerosis (MS). Choosing the effective treatment is very important in improving their quality of life...
10.
Ghadiri F, Sahraian M, Razazian N, Ashtari F, Poursadeghfard M, Nabavi S, et al.
Mult Scler Relat Disord
. 2023 Jan;
70:104493.
PMID: 36638768
Background: Today, it is estimated that around 5% of multiple sclerosis (MS) patients are in the late-onset category (age at disease onset ≥ 50). Diagnosis and treatment in this group...